Results for tag: "Antibody Humanization"

The Antibody Humanization market is a subset of the biopharmaceutical industry that focuses on the development of humanized antibodies. Humanized antibodies are created by transferring the antigen-binding region of a non-human antibody into a human antibody framework. This process is used to create antibodies that are more compatible with the human immune system, allowing them to be used in therapeutic treatments. Humanized antibodies are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. The Antibody Humanization market is highly competitive, with many companies offering a range of services. These services include antibody engineering, antibody humanization, and antibody production. Companies in the market are also involved in the development of novel antibody-based therapeutics. Some companies in the Antibody Humanization market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more